IDM Pharma, Inc. (IDMI)

[bowonwing]

IDM is going to be sold. "Walbert said the company is currently in talks with various parties but declined to comment on the nature of the deals or the companies. Last December, IDM Pharma had said it was planning to manage its cash burn and evaluate strategic alternatives as it expected significant additional costs related to the bone cancer drug."

Walbert (CEO) and executive management working "part-time." IDM does not have the resources to manufacture and market L-MTP-PE in Europe. And as many have said on this mb, in the pipeline, IDM-2101 is the gem of the company.

Buy-out price? I am hoping for >$8 per share (JMHO- it would be a steal) but it could be about $7 or so in this horrific economic environment of late 2008, which I believe will get worse in 2009.